SEC Form 4 · accession 0000059478-17-000049
ELI LILLY & Co · LLY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey N Simmons
Officer — SVP&Pres. Elanco Animal Health
Period of report
Jan 27, 2017
Accepted (ET)
Jan 31, 2017 · 6:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000059478
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 27, 2017 | A | 20,551 | $75.38 | A | 131,509 | D | |
| Common Stock | holding | — | — | — | 1,048 | I | 401(k) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1 | — | Jan 27, 2017 | A | 21,326 | A | Feb 1, 2018 | Feb 1, 2018 | Common Stock | 21,326 | 21,326 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.